USFDA to lift import alert for Divis Laboratories’ Visakhapatnam unit

02 Nov 2017 Evaluate

The US Food and Drug Administration (USFDA) will be lifting the Import Alert 66-40 for Divis Laboratories’ Visakhapatnam unit and moving to close out the Warning letter issued to the company’s Unit-II at Visakhapatnam.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.


Divis Lab Share Price

3452.55 87.80 (2.61%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.